{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T04:18:12Z","timestamp":1745036292683},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,26]]},"DOI":"10.7759\/cureus.27315","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:10:40Z","timestamp":1658880640000},"source":"Crossref","is-referenced-by-count":2,"title":["Acquired Amegakaryocytic Thrombocytopenia Associated With Autoimmune Hemolytic Anemia"],"prefix":"10.7759","author":[{"given":"Naoto","family":"Ikeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Kamao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18235","article-title":"Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia","author":"Roeser A","year":"2022","unstructured":"Roeser A, Moulis G, Ebbo M, et al.. Characteristics, management and outcome of acquired amegakaryocytic thrombocytopenia. Br J Haematol. 2022, 10.1111\/bjh.18235","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20510","article-title":"Acquired amegakaryocytic thrombocytopenic purpura","volume":"81","author":"Agarwal N","year":"2006","unstructured":"Agarwal N, Spahr JE, Werner TL, Newton DL, Rodgers GM. Acquired amegakaryocytic thrombocytopenic purpura. Am J Hematol. 2006, 81:132-5. 10.1002\/ajh.20510","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.18016","article-title":"Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia","volume":"58","author":"Nishino S","year":"2018","unstructured":"Nishino S, Kodaka T, Sawada Y, Goka T, Gotoh Y, Tsunemine H, Takahashi T. Marked rebound thrombocytosis in response to glucocorticoids in a patient with acquired amegakaryocytic thrombocytopenia. J Clin Exp Hematop. 2018, 58:166-70. 10.3960\/jslrt.18016","journal-title":"J Clin Exp Hematop"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/19.203","article-title":"Acquired amegakaryocytic thrombocytopenia misdiagnosed as immune thrombocytopenia: a case report","volume":"24","author":"Roy AM","year":"2020","unstructured":"Roy AM, Konda M, Sidarous GK, Atwal D, Schichman SA, Kunthur A. Acquired amegakaryocytic thrombocytopenia misdiagnosed as immune thrombocytopenia: a case report. Perm J. 2020, 24:1-3. 10.7812\/TPP\/19.203","journal-title":"Perm J"},{"key":"ref5","article-title":"Acquired amegakaryocytic thrombocytopenic purpura treated with intravenous immunoglobulins","volume":"151","author":"El Omri H","year":"2000","unstructured":"El Omri H, Skouri H, Kraiem I, et al.. Acquired amegakaryocytic thrombocytopenic purpura treated with intravenous immunoglobulins. Ann Med Interne (Paris). 2000, 151:223-226.","journal-title":"Ann Med Interne (Paris)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112905","article-title":"Anti thymocyte globulin-based treatment for acquired bone marrow failure in adults","volume":"10","author":"Tjon JM","year":"2021","unstructured":"Tjon JM, Langemeijer SM, Halkes CJ. Anti thymocyte globulin-based treatment for acquired bone marrow failure in adults. Cells. 2021, 10:10.3390\/cells10112905","journal-title":"Cells"},{"key":"ref7","article-title":"Successful rituximab treatment for acquired amegakaryocytic thrombocytopenic purpura complicated with Coombs-negative autoimmune hemolytic anemia","volume":"54","author":"Hashimoto A","year":"2013","unstructured":"Hashimoto A, Fujimi A, Kanisawa Y, et al.. Successful rituximab treatment for acquired amegakaryocytic thrombocytopenic purpura complicated with Coombs-negative autoimmune hemolytic anemia. Rinsho Ketsueki. 2013, 54:568-73.","journal-title":"Rinsho Ketsueki"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.20047","article-title":"Acquired amegakaryocytic thrombocytopenia after durvalumab administration","volume":"61","author":"Suyama T","year":"2021","unstructured":"Suyama T, Hagihara M, Kubota N, Osamura Y, Shinka Y, Miyao N. Acquired amegakaryocytic thrombocytopenia after durvalumab administration. J Clin Exp Hematop. 2021, 61:53-7. 10.3960\/jslrt.20047","journal-title":"J Clin Exp Hematop"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2017.09.001","article-title":"Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation","volume":"12","author":"Simkins A","year":"2019","unstructured":"Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, Oo TH. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2019, 12:115-8. 10.1016\/j.hemonc.2017.09.001","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref10","article-title":"Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE)","volume":"11","author":"Iva C","year":"2010","unstructured":"Iva C, Ira J.M, Robert S.K, Amy R, Jamile M.S. Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE). Clin Adv Hematol Oncol. 2010, 11:806-809.","journal-title":"Clin Adv Hematol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5190","article-title":"Thrombocytopenia and anemia with anti-c-Mpl antibodies effectively treated with cyclosporine in a patient with rheumatoid arthritis and chronic renal failure","volume":"55","author":"Hashimoto A","year":"2016","unstructured":"Hashimoto A, Kanisawa Y, Fujimi A, et al.. Thrombocytopenia and anemia with anti-c-Mpl antibodies effectively treated with cyclosporine in a patient with rheumatoid arthritis and chronic renal failure. Intern Med. 2016, 55:683-7. 10.2169\/internalmedicine.55.5190","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.2929-19","article-title":"Acquired amegakaryocytic thrombocytopenia in adult-onset Still's disease: successful combination therapy with tocilizumab and cyclosporine","volume":"58","author":"Ichikawa T","year":"2019","unstructured":"Ichikawa T, Shimojima Y, Otuki T, Ueno KI, Kishida D, Sekijima Y. Acquired amegakaryocytic thrombocytopenia in adult-onset Still's disease: successful combination therapy with tocilizumab and cyclosporine. Intern Med. 2019, 58:3473-8. 10.2169\/internalmedicine.2929-19","journal-title":"Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0202-8","article-title":"Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease","volume":"27","author":"Her MY","year":"2007","unstructured":"Her MY, Kim TH, Chang HK, Lee WS, Yoo DH. Successful treatment of acquired amegakaryocytic thrombocytopenia with cyclosporine in adult onset Still's disease. Rheumatol Int. 2007, 27:295-8. 10.1007\/s00296-006-0202-8","journal-title":"Rheumatol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.10420","article-title":"Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia","volume":"46","author":"Kuwana M","year":"2002","unstructured":"Kuwana M, Okazaki Y, Kajihara M, Kaburaki J, Miyazaki H, Kawakami Y, Ikeda Y. Autoantibody to c-Mpl (thrombopoietin receptor) in systemic lupus erythematosus: relationship to thrombocytopenia with megakaryocytic hypoplasia. Arthritis Rheum. 2002, 46:2148-59. 10.1002\/art.10420","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel010","article-title":"Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus","volume":"45","author":"Kuwana M","year":"2006","unstructured":"Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006, 45:851-4. 10.1093\/rheumatology\/kel010","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2018.08.021","article-title":"Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO","volume":"170","author":"Jing FM","year":"2018","unstructured":"Jing FM, Zhang XL, Meng FL, et al.. Anti-c-Mpl antibodies in immune thrombocytopenia suppress thrombopoiesis and decrease response to rhTPO. Thromb Res. 2018, 170:200-6. 10.1016\/j.thromres.2018.08.021","journal-title":"Thromb Res"},{"key":"ref17","article-title":"Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura","volume":"76","author":"Mukai HY","year":"1996","unstructured":"Mukai HY, Kojima H, Todokoro K, et al.. Serum thrombopoietin (TPO) levels in patients with amegakaryocytic thrombocytopenia are much higher than those with immune thrombocytopenic purpura. Thromb Haemost. 1996, 76:675-8.","journal-title":"Thromb Haemost"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V60.5.1173.1173","article-title":"Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies","volume":"60","author":"Hoffman R","year":"1982","unstructured":"Hoffman R, Bruno E, Elwell J, et al.. Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood. 1982, 60:1173-1178. 10.1182\/blood.V60.5.1173.1173","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.3.619.619","article-title":"Cell-mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpura","volume":"68","author":"Gewirtz AM","year":"1986","unstructured":"Gewirtz AM, Sacchetti MK, Bien R, Barry WE. Cell-mediated suppression of megakaryocytopoiesis in acquired amegakaryocytic thrombocytopenic purpura. Blood. 1986, 68:619-626. 10.1182\/blood.V68.3.619.619","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/105021-acquired-amegakaryocytic-thrombocytopenia-associated-with-autoimmune-hemolytic-anemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:44Z","timestamp":1707507344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/105021-acquired-amegakaryocytic-thrombocytopenia-associated-with-autoimmune-hemolytic-anemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.27315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,26]]}}}